Teva Pharmaceutical Industries Ltd. has appointed John Nason to lead its Teva Active Pharmaceutical Ingredients unit, the leading global provider of active pharmaceutical ingredients.
As president, Nason will oversee the Teva unit that manufactures generic drugs and a portfolio of specialty medicines. He will be based in Teva's global headquarters in Petach Tikva, Israel.
Nason has worked for Teva since 2015 as senior vice president of European technical operations. According to the company's Sept. 5 statement, he worked at Bristol-Myers Squibb Co. for 12 years prior to his time with Teva.